Clinical Trials in Cleveland

Showing 2461-2480 of 19,775 trials

Observational Study of LUMRYZ in Narcolepsy

NCT06792708

This is an observational study of LUMRYZ prescribed in clinical practice. Patients are asked if they would be willing to complete questionnaires over a 4-month period after starting LUMRYZ. The questionnaires ask about narcolepsy symptoms, experience with LUMRYZ, and quality of life.

Narcolepsy

Avadel71 participantsStarted Jul 2024

Bradenton, Florida, United States • East Lansing, Michigan, United States • Middletown, New Jersey, United States +9 more locations

COMPLETEDPhase 3< 1 mile

A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

NCT05550532

The purpose of this study is to evaluate the efficacy of aticaprant compared with placebo as adjunctive therapy to an antidepressant in improving depressive symptoms in adult participants with major depressive disorder (MDD) with moderate to severe anhedonia (ANH+) who have had an inadequate response to current antidepressant therapy with a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI).

Depressive Disorder, MajorAnhedonia

Janssen Research & Development, LLC444 participantsStarted Dec 2022

Birmingham, Alabama, United States • Lafayette, California, United States • Orange, California, United States +128 more locations

Observational Study of LUMRYZ in Narcolepsy

A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

Find Trials by Condition in Cleveland

Remote Monitoring in Pregnant Women With Congenital Heart Disease Using Wrist Wearables

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.

Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study

Compassionate Use of Concizumab if You Have Haemophilia

Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ)

A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)

Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma

Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment

Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers

REFLECT Scoliosis System Post Approval Study

A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity